Accelerate Diagnostics Price to Book Ratio 2010-2024 | AXDX
Historical price to book ratio values for Accelerate Diagnostics (AXDX) over the last 10 years. The current price to book ratio for Accelerate Diagnostics as of November 22, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Accelerate Diagnostics Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-11-21 | 1.67 | 0.00 | |
| 2024-09-30 | 1.71 | $-1.95 | -0.88 |
| 2024-06-30 | 1.17 | $-1.47 | -0.79 |
| 2024-03-31 | 0.99 | $-1.18 | -0.84 |
| 2023-12-31 | 3.92 | $-1.37 | -2.87 |
| 2023-09-30 | 5.75 | $-2.42 | -2.38 |
| 2023-06-30 | 8.10 | $-2.69 | -3.01 |
| 2023-03-31 | 7.00 | $-3.89 | -1.80 |
| 2022-12-31 | 7.06 | $-2.28 | -3.09 |
| 2022-09-30 | 15.20 | $-1.03 | -14.80 |
| 2022-06-30 | 9.93 | $-7.77 | -1.28 |
| 2022-03-31 | 14.40 | $-8.16 | -1.77 |
| 2021-12-31 | 52.20 | $-5.18 | -10.07 |
| 2021-09-30 | 58.30 | $-6.12 | -9.52 |
| 2021-06-30 | 80.60 | $-11.34 | -7.11 |
| 2021-03-31 | 83.20 | $-11.14 | -7.47 |
| 2020-12-31 | 75.80 | $-10.90 | -6.95 |
| 2020-09-30 | 106.60 | $-8.71 | -12.24 |
| 2020-06-30 | 151.60 | $-6.58 | -23.05 |
| 2020-03-31 | 83.30 | $-4.17 | -19.97 |
| 2019-12-31 | 169.00 | $-1.35 | -125.30 |
| 2019-09-30 | 185.70 | $1.87 | 99.28 |
| 2019-06-30 | 228.80 | $4.77 | 47.96 |
| 2019-03-31 | 210.20 | $7.89 | 26.64 |
| 2018-12-31 | 115.00 | $10.58 | 10.87 |
| 2018-09-30 | 229.50 | $14.28 | 16.07 |
| 2018-06-30 | 223.00 | $17.54 | 12.71 |
| 2018-03-31 | 228.50 | $19.74 | 11.58 |
| 2017-12-31 | 262.00 | $21.32 | 12.29 |
| 2017-09-30 | 224.50 | $23.45 | 9.57 |
| 2017-06-30 | 273.50 | $25.69 | 10.65 |
| 2017-03-31 | 242.00 | $13.29 | 18.21 |
| 2016-12-31 | 207.50 | $15.11 | 13.74 |
| 2016-09-30 | 272.60 | $17.74 | 15.37 |
| 2016-06-30 | 143.90 | $20.51 | 7.02 |
| 2016-03-31 | 143.70 | $23.37 | 6.15 |
| 2015-12-31 | 214.90 | $25.98 | 8.27 |
| 2015-09-30 | 161.80 | $8.98 | 18.01 |
| 2015-06-30 | 258.10 | $11.04 | 23.38 |
| 2015-03-31 | 225.00 | $13.17 | 17.08 |
| 2014-12-31 | 191.90 | $14.78 | 12.98 |
| 2014-09-30 | 214.80 | $16.21 | 13.25 |
| 2014-06-30 | 260.00 | $17.65 | 14.73 |
| 2014-03-31 | 218.10 | $9.26 | 23.55 |
| 2013-12-31 | 122.00 | $9.97 | 12.24 |
| 2013-09-30 | 134.10 | $10.85 | 12.36 |
| 2013-06-30 | 81.20 | $7.09 | 11.46 |
| 2013-03-31 | 72.70 | $7.75 | 9.38 |
| 2012-12-31 | 40.30 | 0.00 | |
| 2012-10-31 | 36.00 | $5.31 | 6.79 |
| 2012-09-30 | 33.30 | 0.00 | |
| 2012-07-31 | 32.70 | 0.00 | |
| 2012-06-30 | 26.90 | 0.00 | |
| 2012-04-30 | 27.30 | $3.62 | 7.54 |
| 2012-03-31 | 10.50 | 0.00 | |
| 2012-01-31 | 12.80 | $4.04 | 3.17 |
| 2011-10-31 | 28.70 | $4.20 | 6.84 |
| 2011-07-31 | 38.90 | 0.00 | |
| 2011-04-30 | 38.60 | $4.50 | 8.58 |
| 2011-01-31 | 13.00 | $4.61 | 2.82 |
| 2010-10-31 | 11.00 | $4.63 | 2.37 |
| 2010-07-31 | 8.70 | 0.00 | |
| 2010-04-30 | 8.30 | $2.89 | 2.87 |
| 2010-01-31 | 6.80 | $3.05 | 2.23 |
| 2009-10-31 | 12.80 | $3.41 | 3.75 |
| 2009-07-31 | 27.00 | 0.00 | |
| 2009-04-30 | 19.80 | $3.89 | 5.08 |
| 2009-01-31 | 22.00 | $4.07 | 5.41 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.041B | $0.012B |
| Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $196.322B | 23.95 |
| Intuitive Surgical (ISRG) | United States | $195.140B | 102.02 |
| Alcon (ALC) | Switzerland | $42.414B | 28.38 |
| Edwards Lifesciences (EW) | United States | $41.569B | 26.40 |
| IQVIA Holdings (IQV) | United States | $36.630B | 20.18 |
| IDEXX Laboratories (IDXX) | United States | $34.166B | 40.24 |
| DexCom (DXCM) | United States | $28.447B | 42.84 |
| Waters (WAT) | United States | $22.175B | 32.79 |
| STERIS (STE) | Ireland | $21.157B | 24.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.795B | 0.00 |
| Hologic (HOLX) | United States | $18.343B | 19.35 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.004B | 13.35 |
| Sysmex ADR (SSMXY) | Japan | $12.946B | 0.00 |
| Globus Medical (GMED) | United States | $11.536B | 29.21 |
| Penumbra (PEN) | United States | $9.397B | 92.04 |
| Masimo (MASI) | United States | $9.260B | 44.81 |
| Teleflex (TFX) | United States | $8.904B | 14.20 |
| Glaukos (GKOS) | United States | $7.940B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.884B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.632B | 26.26 |
| Veracyte (VCYT) | United States | $3.068B | 92.07 |
| Inari Medical (NARI) | United States | $2.907B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.787B | 16.09 |
| TransMedics (TMDX) | United States | $2.552B | 80.89 |
| Nihon Kohden (NHNKY) | Japan | $2.480B | 18.84 |
| Elekta AB (EKTAY) | Sweden | $2.167B | 17.66 |
| Tandem Diabetes Care (TNDM) | United States | $2.023B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.820B | 9.51 |
| RxSight (RXST) | United States | $1.807B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.427B | 0.00 |
| Artivion (AORT) | United States | $1.185B | 78.53 |
| Pulse Biosciences (PLSE) | United States | $1.088B | 0.00 |
| OPKO Health (OPK) | United States | $1.078B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.855B | 14.53 |
| Paragon 28 (FNA) | United States | $0.841B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.723B | 0.00 |
| IRadimed (IRMD) | United States | $0.675B | 36.46 |
| OrthoPediatrics (KIDS) | United States | $0.638B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.593B | 13.97 |
| AxoGen (AXGN) | United States | $0.587B | 0.00 |
| SiBone (SIBN) | United States | $0.527B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.493B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.488B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.463B | 31.05 |
| Tactile Systems Technology (TCMD) | United States | $0.428B | 23.18 |
| CVRx (CVRX) | United States | $0.360B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.326B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.312B | 0.00 |
| NeuroPace (NPCE) | United States | $0.290B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.278B | 0.00 |
| Inogen (INGN) | United States | $0.223B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.204B | 0.00 |
| Accuray (ARAY) | United States | $0.194B | 0.00 |
| Nevro (NVRO) | United States | $0.169B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.162B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.146B | 15.60 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| 908 Devices (MASS) | United States | $0.089B | 0.00 |
| LENSAR (LNSR) | United States | $0.086B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.084B | 0.00 |
| Hyperfine (HYPR) | United States | $0.074B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.068B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.049B | 0.00 |
| Envoy Medical (COCH) | United States | $0.044B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Neuronetics (STIM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Spectral AI (MDAI) | United States | $0.022B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |